Adaptiiv Medical Technologies
A regulatory-cleared software platform that enables the design and 3D printing of patient-specific medical devices and accessories for radiation oncology.
- CEO / Founder
- Erin Creighton
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $10.5M
- Latest Round
- Series A
- Key Investors
- Build Ventures, Nova Scotia Business Inc. (NSBI), Atlantic Canada Opportunities Agency (ACOA), Concrete Ventures
Technology & Products
Key Products
A regulatory-cleared software platform that enables the design and 3D printing of patient-specific medical devices and accessories for radiation oncology.
Technological Advantage
Seamlessly integrates with existing clinical workflows by converting DICOM RT data directly into 3D-printable files, reducing manual labor and eliminating the inaccuracies of traditional wax or plastic boluses.
Differentiation
Value Proposition
Improves clinical precision and patient comfort by replacing generic, hand-made radiotherapy accessories with 3D-printed devices that conform perfectly to a patient’s unique anatomy, ensuring accurate dose delivery while sparing healthy tissue.
How They Differentiate
Adaptiiv differentiates through a software-first, vendor-neutral approach that integrates directly with existing Treatment Planning Systems (TPS). Unlike competitors that focus on centralized manufacturing (like .decimal), Adaptiiv enables clinics to design and 3D print patient-specific devices locally, reducing turnaround time from weeks to hours.
Market & Competition
Target Customers
Radiation oncology clinics, hospitals, medical physicists, and radiation therapists at cancer treatment centers.
Industry Verticals
["Healthcare","Medical Devices","Radiation Oncology","Additive Manufacturing (3D Printing)"]
Competitors
.decimal (Dot Decimal); 3D Systems (Healthcare Division); Stratasys (Medical Solutions)
Growth & Milestones
Growth Metrics
Expanded clinical footprint to over 20 countries; Gold Tier Alliance Member in Varian’s 3cosystem.
Major Milestones
["Received first FDA 510(k) clearance for 3D Bolus software in 2018","Established strategic partnership with HP for Multi Jet Fusion integration in 2020","Secured $5M Series A funding led by Build Ventures in 2021","Achieved CE Mark and TGA approvals for international expansion","Partnered with Varian (Siemens Healthineers) for global distribution"]
Notable Customers
Mayo Clinic; MD Anderson Cancer Center; Nova Scotia Health; BC Cancer - Kelowna